Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

418
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
418
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

124
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
124
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

2.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.1K
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

114
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
114
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing antibody-antigen interaction prediction with atomic flexibility.

PLoS computational biology·2025
Same author

Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents.

NPJ vaccines·2024
Same author

An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease.

NPJ systems biology and applications·2024
Same author

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Cell reports·2024
Same author

Antibody design using deep learning: from sequence and structure design to affinity maturation.

Briefings in bioinformatics·2024
Same author

Deep-learning image analysis for high-throughput screening of opsono-phagocytosis-promoting monoclonal antibodies against Neisseria gonorrhoeae.

Scientific reports·2024
Same journal

Host immunity and recurrent <i>Clostridioides difficile</i> infection: a comprehensive review.

Pathogens and global health·2026
Same journal

Genetic variability of SARS-CoV-2 XFG lineage and its parental lineages.

Pathogens and global health·2026
Same journal

Study of <i>Leptospira</i> spp. in rodents and water sources: implications for public health in rural environments from Buenos Aires province, Argentina.

Pathogens and global health·2026
Same journal

Designing out rabies: a conceptual urban planning framework for dog-mediated rabies control in informal settlements.

Pathogens and global health·2026
Same journal

Trends in hospitalizations in adults with HIV infection in Spain over 25 years.

Pathogens and global health·2026
Same journal

What can be learnt from India's success in controlling <i>Anopheles stephensi</i> in urban systems.

Pathogens and global health·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.7K

Bexsero® chronicle.

George Vernikos, Duccio Medini

    Pathogens and Global Health
    |November 25, 2014
    PubMed
    Summary
    This summary is machine-generated.

    A novel genome-based approach, reverse vaccinology, led to the first broadly effective serogroup B meningococcus (MenB) vaccine. This innovation combats a devastating invasive disease responsible for significant global mortality.

    Keywords:
    4CMenB,Antigen Typing System (MATS)Bexsero,Meningococcal,Neisseria meningitidis,Serogroup B meningitis,

    More Related Videos

    Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
    08:31

    Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

    Published on: September 20, 2021

    3.9K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    13.0K

    Related Experiment Videos

    Last Updated: Apr 20, 2026

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
    10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    2.7K
    Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
    08:31

    Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

    Published on: September 20, 2021

    3.9K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    13.0K

    Area of Science:

    • Microbiology
    • Vaccinology
    • Genomics

    Background:

    • Neisseria meningitidis causes significant global mortality, particularly in infants and adolescents.
    • Traditional vaccinology approaches failed to produce an effective vaccine against serogroup B meningococcus (MenB).
    • Serogroup B meningococcus is a leading cause of invasive meningococcal disease in developed nations.

    Observation:

    • The first complete genome sequence of a living organism was published 18 years ago.
    • Reverse vaccinology, a genome-based strategy, enabled novel antigen discovery.
    • This approach facilitated the development of a broadly effective MenB vaccine.

    Findings:

    • The first broadly effective MenB vaccine was licensed by regulatory authorities, including the European Medical Agency.
    • The vaccine is currently being implemented globally.
    • This represents a significant advancement in combating invasive meningococcal disease.

    Implications:

    • Reverse vaccinology offers a powerful new paradigm for vaccine development against challenging pathogens.
    • The MenB vaccine significantly impacts public health by reducing invasive disease burden.
    • Two decades of scientific innovation have culminated in overcoming a devastating infectious disease.